Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1988-07-05
1992-01-14
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514824, 536 24, 536 28, 536 27, A61K 2700
Patent
active
050811096
ABSTRACT:
The use of pharmaceutical compositions containing as the active ingredient Defibrotide permits peripheral arteriopathies in advanced phase (phase III and IV) to be treated by a therapeutical route.
REFERENCES:
patent: 3770720 (1973-11-01), Butti et al.
patent: 3829567 (1974-08-01), Butti et al.
patent: 3899481 (1975-08-01), Butti et al.
patent: 4309364 (1982-01-01), Bentzen et al.
patent: 4351950 (1982-09-01), Sircar
patent: 4366161 (1982-12-01), Mori et al.
patent: 4416877 (1983-11-01), Bentzen et al.
patent: 4450272 (1984-05-01), Du et al.
patent: 4485105 (1984-11-01), Shephard
patent: 4614744 (1986-09-01), Bellani et al.
patent: 4649134 (1987-03-01), Bonomini
patent: 4693995 (1987-09-01), Prino et al.
Ulutin et al., Abstract No. 107, VIII International Congress on Thrombosis, Istanbul, Turkey, Jun. 4-7, 1984.
Gelister et al., Abstract No. 108, VIII International Congress on Thrombosis, Istanbul, Turkey, Jun. 4-7, 1984.
Pescador et al., Pharmacokinetics of Defibrotide and of Hs Profibrinolytic Activity in the Rabbit, Thrombosis Research 30, 1-11 (1983).
Abstract No. 1162, Thrombosis and Hemostasis 42, 4747 (1979).
Modern Drug Encyclopedia, pp. 871-873, 973 and 974 MDE/16.
Pharmacological Basis of Therapeutics, pp. 1360-1362 (Sixth Ed.), MacMillan Publishing Co., Inc.
Thrombosis, Haemostas (Abstr. VIIth Internat. Cong. Jul. 1979), No. 1162.
Haemostasis, Mar. 1984 (7th Internat. Cong. on Fibrinolipis), Abstracts 226, 227 and 228.
Crinos Industria Farmacobiolgica SpA
Griffin Ronald W.
LandOfFree
Pharmaceutical composition and method for the therapy of periphe does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition and method for the therapy of periphe, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition and method for the therapy of periphe will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-541699